检索结果-南通市图书馆

动脉瘤所致蛛网膜下腔出血后脑血管痉挛治疗的系统性回顾与meta分析

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

国际医学放射学杂志 2017年第5期 616-616页

作者： G.Boulouis M.A.Labeyrie J.Raymond C.Rodriguez-Régent A.C.Lukaszewicz d.bresson 华蓓 INSERM U894 CH Sainte-AnneDepartment of NeuroradiologyUniversité Paris-Descartes

摘要目的采用meta分析评估动脉瘤所致蛛网膜下腔出血(a SAH)出现脑血管痉挛(CVS)并采用靶向治疗病人的临床预后,以及评估严重/难治性血管痉挛病人动脉内(IA)

关键词：难治性 CVS 动脉瘤末次随访血管痉挛

Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2006年第45期12卷 7319-7325页

作者： Thomas decaens Franoise Roudot-Thoraval Solange bresson-Hadni Carole Meyer Jean Gugenheim Francois durand Pierre-Henri Bernard Olivier Boillot Philippe Compagnon Yvon Calmus Jean Hardwigsen Christian ducerf Georges Philippe Pageaux Sébastien dharancy Olivier Chazouillères daniel Cherqui Christophe duvoux Service d'Hépatologie et de Gastroentérologie AP-HP Hpital Henri Mondor Créteil Unité INSERM 581 France département de Santé Publique AP-HP Hpital Henri Mondor Créteil France Service d’Hépatologie Hpital Jean Minjoz Besanon France Service de Transplantation Hpital HautefeuilleStrasbourg France Service de Chirurgie digestive Hpital L’Ar-chet 2 Nice France Service d’Hépatologie AP-HP Hpital Beau-jon Clichy France Service d’Hépatologie et de Gastroentéro-logie H?pital Pellegrin Bordeaux France Service de Chirurgie digestive Hpital Edouard Herriot Lyon France Service de Chirurgie digestive Hpital Ponchaillou Rennes France Service de Chirurgie digestive AP-HP HpitalCochin Paris France Service de Chirurgie digestive Hpital laConception Marseille France Service de Chirurgie digestive Hpital de laCroix Rousse Lyon France Fédération Médico-Chirurgicale deMaladies de l’Appareil digestif Hpital Saint-Eloi MontpellierFrance Service d’Hépatologie et de Gastroentérologie H?pital Claude Huriez Lille France Service d’Hépatologie AP-HP Hpital SAntoine Paris France Service de Chirurgie Générale et digestive APHP Hopital Henri Mondor Créteil France

AIM： To assess pre-orthotopic liver transplantation （OLT） factors that could be evaluated pre-operatively or controlled post-operatively associated with hepatocellular carcinoma （HCC） recurrence and disease-free survival after liver transplantation （LT）.METHOdS： Four hundred and twelve patients transplanted for HCC between 1988 and 1998 in 14 French centers, who survived the postoperative period were studied. Kaplan Meier estimates were calculated for 24 variables potentially associated with recurrence of HCC. Uni- and multivariate analyses were conducted to identify independent predictors of recurrence. RESULTS： Overall 5-year disease-free survival was 57.1%. By univariate analysis, variables associated with disease-free survival were： presence of cirrhosis （P = 0.001）, etiology of liver disease （P = 0.03）, α fetoprotein level （〈 200, 200 to 2000, or 〉 2000; P 〈 0.0001）, y-GT activity （N, N to 2N or 〉 2N; P = 0.02）, the number of nodules （1, 2-3 or ≥ 4; P = 0.02）, maximal diameter of the largest nodule （〈 3 cm, 3 to 5 cm or 〉 5 cm; P 〈 0.0001）, the sum of the diameter of the nodules （〈 3 cm, 3 to 5 cm, 5 to 10 cm or 〉10 cm; P 〈 0.0001）, bilobar location （P = 0.01）, preoperative portal thrombosis （P 〈 0.0001）, peri-operative treatment of the tumor （P = 0.002） and chemoembolization （P = 0.03）, tumor differentiation （P = 0.01）, initial type of calcineurin inhibitor （P = 0.003）, the use of antilymphocyte antibodies （P = 0.02）, rejection episodes （P = 0.003） and period of LT （P 〈 0.0001）. By multivariate analysis, 6 variables were independently associated with HCC recurrence： maximal diameter of the largest nodule （P 〈 0.0001）, time of LT （P 〈 0.0001）, tumor differentiation （P 〈 0.0001）, use of anti-lymphocyte antibody （ATG） or anti-Cd3 antibody （OKT3）（P = 0.005）, preoperative portal thrombosis （P = 0.06） and the number of nodules （P = 0.06）. CONCLUSION： This study identifies immunosuppression, through the use of ATG or OKT3, as a predictive factor of tumor recur

关键词： Immunosuppression Hepatocellular carcinoma Tumor differentiation Liver transplantation

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

法国烟雾血管病临床实践指南

国际脑血管病杂志 2018年第5期26卷 321-330页

作者： d. Herve() M. Kossorotoff() d. bresson() T. Blauwblomme() M. Carneiro() E. Touze() F. Proust() I. desguerre() S. Alamowitch() J.-P. Bleton() A. Borsali() E. Brissaud F.Brunelle() L. Calviere() M. Chevignard() G. Geffroy-Greco() S. Faesch() M.-O. Habert() H.de Larocque() P. Meyer() S. Reyes L. Thines() E. Tournier-Lasserve() H.Chabriat 郝方斌(译) 张勇(译) 韩聪(译) 段炼(译) From the departement de neurologie centre de reference des maladies vasculaires rares du cerveau et de roeil (CERVCO) groupe hospitalier Saint- Louis-Lariboisiere-Femand-Widal 2 rue Ambroise-Pare 75010 Paris France Centre national de reference de I’AVC de l’enfant hopital universitaire Necker-Enfants malades AP-HP 149 rue de Sevres 75015 Paris France Service de neurochirurgie groupe hospitalier Saint-Louis-Lariboisiere-Fernand-Widal 2 rue Ambroise- Pare 75010 Paris France Service de neurochirurgie pediatrique hopital universitaire Necker-Enfants-Malades AP-HP 149 rue de Sevres 75015 Paris France Neurologie pediatrique hopital Femme-Mere-Enfant hospices Civils-de-Lyon 59 boulevard Pinel 69677 Bron France Service de neurologie Normandie universite Unicaen Inserm U1237 CHU Caen-Normandie avenue de la Cotede-Nacre 14033 Caen France Service de neurochirttrgie CHRU de Rouen 1 rue Germont 76000 Rouen France Service de neuropediatrie hopital universitaire Necker-Enfants malades AP-HP 149 rue de Sevres 75015 Paris France Service de neurologie CHU Saint-Antoine AP-HP 184 rue du Faubourg-Saint-Antoine 75012 Paris France Cabinet de kinesitherapie 25 rue Manin 75019 Paris France departement d’anesthesie-reanimation groupe hospitalier Saint-Louis-Lariboisiere-Fernand Widal 2 rue Ambroise-Pare 75010 Paris France Cabinet medical de neurologie 132 rue Lafayette 75010 Paris France Service de radiologie petiatrique hopital universitaire Necker- Enfants malades AP-HP 149 rue de Sevres 75015 Paris France Unite neurovasculaire hopital Pierre-Paul-Riquet place du Dr-Baylac 31000 Toulouse France Service de reeducation des pathologies neurologiques acquises de renfant hopitaux de Saint-Maurice 12 rue du Vald’Osne 94410 Saint-Maurice France Centre medical mairie de Port-Marly 78560 Le-Port-Marly France Cabinet medical pediatrique 46 rue Vital 75016 Paris France Service de medecine nucleaire groupe hospitalier Pitie-Salpetriere- Charle-Foix 47-83 bou

1序言1．1制定机构本指南在法国卫生部的组织下由法国脑部和眼部罕见血管疾病中心（reference center for rare vascular diseases of the brain and eye，CERVCO）与法国儿童卒中中心联合起草。

关键词：临床实践指南法国血管病 diseases 烟雾 brain 血管疾病卒中中心

维普期刊数据库

The Vibrational Behavior of the Mixture Quercetin/Gelucire 50/13 at Room and Body Temperature

在线全文

学校读者我要写书评

暂无评论

材料科学与工程（中英文B版） 2021年第3期11卷 98-108页

作者： M.El Hadri B.Khelifa V.Faivre O.Abbas S.bresson Laboratory of Condensed Matter Physics Abdelmalek Essaâdi UniversityTetouan 93000Morocco Faculty of Science University of ArtoisLens 62300France Polyphase Systems Physical Chemistry Team UMR CNRS 8612Labex LERMITUniversity of Paris SudParis 75000France Walloon Agricultural Research Centre(CRA-W) Valorisation of Agricultural ProductsDepartmentFood and Feed Quality Unit(U15)Gembloux 5030Belgium Institut Polytechnique UniLaSalle Universitéd’ArtoisULR 751919 Rue Pierre WaguetBP 30313Beauvais 60026France

The present paper discusses the vibrational properties of the mixture gelucire-quercetin(from 1%to 5%)at room and body *** is a flavonoid having beneficial properties:biological and antioxidant;it is used in many fields as food,cosmetic and especially pharmaceutics but its use as a drug is affected by its low *** Gelucire 50/13 is used as sustained release matrix forming agent in pharmaceutical applications and it has demonstrated the ability to improve the dissolution as well as the absorption of poorly water-soluble *** mixture Gelucire-quercetin was essentially studied by FTIR(Fourier transform infrared spectroscopy)and Raman *** behavior of these two molecules has been investigated in the spectral range 4000-0 cm-1 in Raman spectroscopy,and 4,000-600 cm-1 in FTIR.

关键词： Gelucire 50/13 quercetin solubility Raman spectroscopy IR spectroscopy

居住地与医疗机构的距离对丙型肝炎诊断的影响:一项基于人群的研究

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

世界核心医学期刊文摘（胃肠病学分册） 2006年第8期2卷 56-56页

作者： Monnet E. Collin-Naudet E. bresson-Hadni S. 孟欣颖(译) 王顺涛(校) Service d'Hépatologie et de Soins Intensifs CHU Jean Minjoz 1 Boulevard Fleming 25030 Besancon Cedex France 不详

Background/Aims: In France, geographic access to medical care may affect the diagnosis of hepatitis C. The aims of this study were to compare the detection rates of hepatitis C in urban and rural areas after adjusting for distance to medical care, and evaluating the impact of the place of residence on patients’ clinical characteristics. Methods: Between 1994 and 2001, 1938 newly detected cases were recorded in a French population of 1,005,817 inhabitants. Age and sex-adjusted detection rates for 105 inhabitants were estimated for urban and rural areas and for classes of distance to the nearest practitioner. Results: detection rates were lower in rural than in urban areas [14.1, (95CI: 12.5- 15.7) versus 24.7 (95CI: 23.5- 26.0)] and decreased as the distance to the general practitioner increased [27.0 (95CI: 25.5- 28.4) versus 13.7 (95CI: 12.1- 15.3) for a cutoff value of 1.5 km]. In multivariate analyses, detection rates were only influenced by the distance to general practitioner. Hepatocellular carcinoma at diagnosis was more frequent among rural than among urban patients (adjusted OR=2.28,95CI: 0.97- 5.39, P=0.059). Conclusions: A poorer geographic access to care explained the lower detection of hepatitis C in rural areas. Hepatocellular carcinoma was more frequent in rural patients. It may result from later detection and/or involvement of environmental factors on hepatocarcinogenesis.

关键词：丙型肝炎患者医疗机构肝炎诊断居住地距离乡村地区肝细胞肝癌人群检出率多变量分析

维普期刊数据库